We show here that SPRYD7 plays an important role in CRC and in CRC progression; thus, our results should increase interest in the role of SPRYD7 in CRC, as well as those of its interactors as potential therapeutic targets for CRC. The gene discussed is SPRYD7; the disease is colorectal carcinoma.